1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Gastric Cancer Therapeutics Market
4.
Executive Summary
5. Voice of Customer
6. Global Gastric
Cancer Therapeutics Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Therapy Type (Chemotherapy,
Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery)
6.2.2. By Disease
Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST), Gastric
Neuroendocrine Tumors (gNET))
6.2.3. By Molecule Type
(Small Molecule, Biologics)
6.2.4. By Line of Therapy
(Neoadjuvant and Adjuvant, First Line Therapy, Second Line Therapy)
6.2.5. By Mode of Action (Programmed
Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor
(HER2) Antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR)
Antagonists, Others (Microtubule Inhibitors, Kinase Inhibitors))
6.2.6. By Route of
Administration (Oral vs. Parenteral)
6.2.7. By End User
(Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
6.2.8. By Distribution
channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
6.2.9. By Company (2021)
6.2.10. By
Region
6.3. Product
Market Map
7. Asia-Pacific Gastric
Cancer Therapeutics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Therapy Type
7.2.2. By Disease
Indication
7.2.3. By Molecule Type
7.2.4. By Line of Therapy
7.2.5. By Mode of Action
7.2.6. By Route of
Administration
7.2.7. By End User
7.2.8. By Distribution
Channel
7.2.9.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Gastric Cancer Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Therapy Type
7.3.1.2.2.
By Disease Indication
7.3.1.2.3.
By Molecule Type
7.3.1.2.4.
By Line of Therapy
7.3.1.2.5.
By Mode of Action
7.3.1.2.6.
By Route of Administration
7.3.1.2.7.
By End User
7.3.1.2.8.
By Distribution Channel
7.3.2.
India Gastric Cancer Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Therapy Type
7.3.2.2.2.
By Disease Indication
7.3.2.2.3.
By Molecule Type
7.3.2.2.4.
By Line of Therapy
7.3.2.2.5.
By Mode of Action
7.3.2.2.6.
By Route of Administration
7.3.2.2.7.
By End User
7.3.2.2.8.
By Distribution Channel
7.3.3.
Japan Gastric Cancer Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Therapy Type
7.3.3.2.2.
By Disease Indication
7.3.3.2.3.
By Molecule Type
7.3.3.2.4.
By Line of Therapy
7.3.3.2.5.
By Mode of Action
7.3.3.2.6.
By Route of Administration
7.3.3.2.7.
By End User
7.3.3.2.8.
By Distribution Channel
7.3.4.
South Korea Gastric Cancer Therapeutics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Therapy Type
7.3.4.2.2.
By Disease Indication
7.3.4.2.3.
By Molecule Type
7.3.4.2.4.
By Line of Therapy
7.3.4.2.5.
By Mode of Action
7.3.4.2.6.
By Route of Administration
7.3.4.2.7.
By End User
7.3.4.2.8.
By Distribution Channel
7.3.5.
Australia Gastric Cancer Therapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Therapy Type
7.3.5.2.2.
By Disease Indication
7.3.5.2.3.
By Molecule Type
7.3.5.2.4.
By Line of Therapy
7.3.5.2.5.
By Mode of Action
7.3.5.2.6.
By Route of Administration
7.3.5.2.7.
By End User
7.3.5.2.8.
By Distribution Channel
8. Europe Gastric
Cancer Therapeutics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Therapy Type
8.2.2. By Disease
Indication
8.2.3. By Molecule Type
8.2.4. By Line of Therapy
8.2.5. By Mode of Action
8.2.6. By Route of
Administration
8.2.7. By End User
8.2.8. By Distribution
Channel
8.2.9.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Gastric Cancer Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Therapy Type
8.3.1.2.2.
By Disease Indication
8.3.1.2.3.
By Molecule Type
8.3.1.2.4.
By Line of Therapy
8.3.1.2.5.
By Mode of Action
8.3.1.2.6.
By Route of Administration
8.3.1.2.7.
By End User
8.3.1.2.8.
By Distribution Channel
8.3.2.
Germany Gastric Cancer Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Therapy Type
8.3.2.2.2.
By Disease Indication
8.3.2.2.3.
By Molecule Type
8.3.2.2.4.
By Line of Therapy
8.3.2.2.5.
By Mode of Action
8.3.2.2.6.
By Route of Administration
8.3.2.2.7.
By End User
8.3.2.2.8.
By Distribution Channel
8.3.3.
United Kingdom Gastric Cancer Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Therapy Type
8.3.3.2.2.
By Disease Indication
8.3.3.2.3.
By Molecule Type
8.3.3.2.4.
By Line of Therapy
8.3.3.2.5.
By Mode of Action
8.3.3.2.6.
By Route of Administration
8.3.3.2.7.
By End User
8.3.3.2.8.
By Distribution Channel
8.3.4.
Italy Gastric Cancer Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Therapy Type
8.3.4.2.2.
By Disease Indication
8.3.4.2.3.
By Molecule Type
8.3.4.2.4.
By Line of Therapy
8.3.4.2.5.
By Mode of Action
8.3.4.2.6.
By Route of Administration
8.3.4.2.7.
By End User
8.3.4.2.8.
By Distribution Channel
8.3.5.
Spain Gastric Cancer Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Therapy Type
8.3.5.2.2.
By Disease Indication
8.3.5.2.3.
By Molecule Type
8.3.5.2.4.
By Line of Therapy
8.3.5.2.5.
By Mode of Action
8.3.5.2.6.
By Route of Administration
8.3.5.2.7.
By End User
8.3.5.2.8.
By Distribution Channel
9. North America Gastric
Cancer Therapeutics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Therapy Type
9.2.2. By Disease
Indication
9.2.3. By Molecule Type
9.2.4. By Line of Therapy
9.2.5. By Mode of Action
9.2.6. By Route of
Administration
9.2.7. By End User
9.2.8. By Distribution
Channel
9.2.9.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Gastric Cancer Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Therapy Type
9.3.1.2.2.
By Disease Indication
9.3.1.2.3.
By Molecule Type
9.3.1.2.4.
By Line of Therapy
9.3.1.2.5.
By Mode of Action
9.3.1.2.6.
By Route of Administration
9.3.1.2.7.
By End User
9.3.1.2.8.
By Distribution Channel
9.3.2.
Mexico Gastric Cancer Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Therapy Type
9.3.2.2.2.
By Disease Indication
9.3.2.2.3.
By Molecule Type
9.3.2.2.4.
By Line of Therapy
9.3.2.2.5.
By Mode of Action
9.3.2.2.6.
By Route of Administration
9.3.2.2.7.
By End User
9.3.2.2.8.
By Distribution Channel
9.3.3.
Canada Gastric Cancer Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Therapy Type
9.3.3.2.2.
By Disease Indication
9.3.3.2.3.
By Molecule Type
9.3.3.2.4.
By Line of Therapy
9.3.3.2.5.
By Mode of Action
9.3.3.2.6.
By Route of Administration
9.3.3.2.7.
By End User
9.3.3.2.8.
By Distribution Channel
10. South America Gastric
Cancer Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Therapy Type
10.2.2. By Disease
Indication
10.2.3. By Molecule Type
10.2.4. By Line of Therapy
10.2.5. By Mode of Action
10.2.6. By Route of
Administration
10.2.7. By End User
10.2.8. By Distribution
Channel
10.2.9.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Gastric Cancer Therapeutics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Therapy Type
10.3.1.2.2.
By Disease Indication
10.3.1.2.3.
By Molecule Type
10.3.1.2.4.
By Line of Therapy
10.3.1.2.5.
By Mode of Action
10.3.1.2.6.
By Route of Administration
10.3.1.2.7.
By End User
10.3.1.2.8.
By Distribution Channel
10.3.2.
Argentina Gastric Cancer Therapeutics Market Outlook